TY - JOUR
T1 - Effects of balanced solution on short-term outcomes in traumatic brain injury patients
T2 - a secondary analysis of the BaSICS randomized trial
AU - Zampieri, Fernando Godinho
AU - Damiani, Lucas Petri
AU - Biondi, Rodrigo Santos
AU - Rezende Freitas, Flávio Geraldo
AU - Veiga, Viviane Cordeiro
AU - Figueiredo, Rodrigo Cruvinel
AU - Serpa-Neto, Ary
AU - de Oliveira Manoel, Airton Leonardo
AU - Miranda, Tamiris Abait
AU - Corrêa, Thiago Domingos
AU - de Azevedo, Luciano César Pontes
AU - da Silva, Nilton Brandão
AU - Machado, Flavia Ribeiro
AU - Cavalcanti, Alexandre Biasi
N1 - Funding Information:
Funding: The BaSICS trial was funded by the Brazilian Ministry of Health through Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde (PROADI-SUS). Fluids and logistics for the trial were provided by Baxter Hospitalar, which was not otherwise involved in the trial.
Publisher Copyright:
© 2023 Associacao de Medicina Intensiva Brasileira - AMIB. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Objective: To describe the effects of balanced solution use on the short-term outcomes of patients with traumatic brain injury enrolled in BaSICS trial. Methods: Patients were randomized to receive either 0.9% saline or balanced solution during their intensive care unit stay. The primary endpoint was 90-day mortality, and the secondary outcomes were days alive and free of intensive care unit stay at 28 days. The primary endpoint was assessed using Bayesian logistic regression. The secondary endpoint was assessed using a Bayesian zero-inflated beta binomial regression. Results: We included 483 patients (236 in the 0.9% saline arm and 247 in the balanced solution arm). A total of 338 patients (70%) with a Glasgow coma scale score ≤ 12 were enrolled. The overall probability that balanced solutions were associated with higher 90-day mortality was 0.98 (OR 1.48; 95%CrI 1.04 - 2.09); this mortality increment was particularly noticeable in patients with a Glasgow coma scale score below 6 at enrollment (probability of harm of 0.99). Balanced solutions were associated with -1.64 days alive and free of intensive care unit at 28 days (95%CrI -3.32 - 0.00) with a probability of harm of 0.97. Conclusion: There was a high probability that balanced solutions were associated with high 90-day mortality and fewer days alive and free of intensive care units at 28 days.
AB - Objective: To describe the effects of balanced solution use on the short-term outcomes of patients with traumatic brain injury enrolled in BaSICS trial. Methods: Patients were randomized to receive either 0.9% saline or balanced solution during their intensive care unit stay. The primary endpoint was 90-day mortality, and the secondary outcomes were days alive and free of intensive care unit stay at 28 days. The primary endpoint was assessed using Bayesian logistic regression. The secondary endpoint was assessed using a Bayesian zero-inflated beta binomial regression. Results: We included 483 patients (236 in the 0.9% saline arm and 247 in the balanced solution arm). A total of 338 patients (70%) with a Glasgow coma scale score ≤ 12 were enrolled. The overall probability that balanced solutions were associated with higher 90-day mortality was 0.98 (OR 1.48; 95%CrI 1.04 - 2.09); this mortality increment was particularly noticeable in patients with a Glasgow coma scale score below 6 at enrollment (probability of harm of 0.99). Balanced solutions were associated with -1.64 days alive and free of intensive care unit at 28 days (95%CrI -3.32 - 0.00) with a probability of harm of 0.97. Conclusion: There was a high probability that balanced solutions were associated with high 90-day mortality and fewer days alive and free of intensive care units at 28 days.
KW - Balanced solutions
KW - Brain injuries, traumatic
KW - Critical care
KW - Hospital mortality
KW - Mortality
KW - Saline solution
UR - https://www.scopus.com/pages/publications/85148914637
U2 - 10.5935/0103-507X.20220261-en
DO - 10.5935/0103-507X.20220261-en
M3 - Article
AN - SCOPUS:85148914637
SN - 0103-507X
VL - 34
SP - 410
EP - 417
JO - Revista Brasileira de Terapia Intensiva
JF - Revista Brasileira de Terapia Intensiva
IS - 4
ER -